TrialRMD open2023

Changes in body weight and body composition in patients with active rheumatoid arthritis aged 65+ treated with 2-year low-dose add-on prednisolone in the randomised double-blind placebo-controlled GLORIA trial.

Melek Güler-Yüksel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.